From: Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: A randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome
Placebo mortality
Salbutamol mortality
80% power
90% power
40%
32%
1164
1558
42%
33.6%
1076
1440
44%
35.2%
998
1334
46%
36.8%
926
1238
48%
38.4%
860
1148
50%
798
1068